Curileum

Discovering and validating novel stem cell targets to regenerate the mucosal barrier and restore health to the intestinal tissues.

placeLondon, England, United Kingdom calendar_todayFounded 2013 groups6 employees language curileum.com

Registered entities

Investor mix

62 investors on record.

Investor typeCountShare
Venture capital12%
Other / undisclosed6198%
Coming soon